INSMED INC Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities
INSMED INC (INSM) reported Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities of 0 shares for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-07.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities · last filed 2026-05-07
- INSMED INC incremental common shares attributable to dilutive effect of conversion of debt securities for the quarter ending 2026-03-31 was 0.00 shares.
- INSMED INC incremental common shares attributable to dilutive effect of conversion of debt securities for the quarter ending 2025-09-30 was 0.00 shares.
- INSMED INC incremental common shares attributable to dilutive effect of conversion of debt securities for the quarter ending 2025-06-30 was 0.00 shares.
- INSMED INC incremental common shares attributable to dilutive effect of conversion of debt securities for the quarter ending 2025-03-31 was 0.00 shares.
- INSMED INC incremental common shares attributable to dilutive effect of conversion of debt securities for fiscal 2025 was 0.00 shares.
- INSMED INC incremental common shares attributable to dilutive effect of conversion of debt securities for fiscal 2024 was 0.00 shares.
- INSMED INC incremental common shares attributable to dilutive effect of conversion of debt securities for fiscal 2023 was 0.00 shares.
- INSMED INC incremental common shares attributable to dilutive effect of conversion of debt securities for fiscal 2022 was 0.00 shares.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities 3 month | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities 6 month | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities 9 month | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities 12 month |
|---|---|---|---|---|
| 2026-03-31 | 0.00 shares 10-Q · filed 2026-05-07 | |||
| 2025-12-31 | 0.00 shares 10-K · filed 2026-02-19 | |||
| 2025-09-30 | 0.00 shares 10-Q · filed 2025-10-30 | 0.00 shares 10-Q · filed 2025-10-30 | ||
| 2025-06-30 | 0.00 shares 10-Q · filed 2025-08-07 | 0.00 shares 10-Q · filed 2025-08-07 | ||
| 2025-03-31 | 0.00 shares 10-Q · filed 2026-05-07 | |||
| 2024-12-31 | 0.00 shares 10-K · filed 2026-02-19 | |||
| 2024-09-30 | 0.00 shares 10-Q · filed 2025-10-30 | 0.00 shares 10-Q · filed 2025-10-30 | ||
| 2024-06-30 | 0.00 shares 10-Q · filed 2025-08-07 | 0.00 shares 10-Q · filed 2025-08-07 | ||
| 2024-03-31 | 0.00 shares 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | 0.00 shares 10-K · filed 2026-02-19 | |||
| 2023-09-30 | 0.00 shares 10-Q · filed 2024-10-31 | 0.00 shares 10-Q · filed 2024-10-31 | ||
| 2023-06-30 | 0.00 shares 10-Q · filed 2024-08-08 | 0.00 shares 10-Q · filed 2024-08-08 | ||
| 2023-03-31 | 0.00 shares 10-Q · filed 2024-05-09 | |||
| 2022-12-31 | 0.00 shares 10-K · filed 2025-02-20 | |||
| 2022-09-30 | 0.00 shares 10-Q · filed 2023-10-26 | 0.00 shares 10-Q · filed 2023-10-26 | ||
| 2022-06-30 | 0.00 shares 10-Q · filed 2023-08-03 | 0.00 shares 10-Q · filed 2023-08-03 | ||
| 2022-03-31 | 0.00 shares 10-Q · filed 2023-05-04 | |||
| 2021-12-31 | 0.00 shares 10-K · filed 2024-02-22 | |||
| 2021-09-30 | 0.00 shares 10-Q · filed 2022-10-27 | 0.00 shares 10-Q · filed 2022-10-27 | ||
| 2021-06-30 | 0.00 shares 10-Q · filed 2022-08-04 | 0.00 shares 10-Q · filed 2022-08-04 | ||
| 2021-03-31 | 0.00 shares 10-Q · filed 2022-05-05 | |||
| 2020-12-31 | 0.00 shares 10-K · filed 2023-02-23 | |||
| 2020-09-30 | 0.00 shares 10-Q · filed 2021-10-28 | 0.00 shares 10-Q · filed 2021-10-28 | ||
| 2020-06-30 | 0.00 shares 10-Q · filed 2021-08-05 | 0.00 shares 10-Q · filed 2021-08-05 | ||
| 2020-03-31 | 0.00 shares 10-Q · filed 2021-05-06 | |||
| 2019-12-31 | 0.00 shares 10-K · filed 2022-02-17 | |||
| 2019-09-30 | 0.00 shares 10-Q · filed 2020-10-29 | 0.00 shares 10-Q · filed 2020-10-29 | ||
| 2019-06-30 | 0.00 shares 10-Q · filed 2020-08-06 | 0.00 shares 10-Q · filed 2020-08-06 | ||
| 2019-03-31 | 0.00 shares 10-Q · filed 2020-04-30 | |||
| 2018-09-30 | 0.00 shares 10-Q · filed 2019-10-30 | 0.00 shares 10-Q · filed 2019-10-30 | ||
| 2018-06-30 | 0.00 shares 10-Q · filed 2019-08-01 | 0.00 shares 10-Q · filed 2019-08-01 | ||
| 2018-03-31 | 0.00 shares 10-Q · filed 2019-05-07 | |||
| 2017-09-30 | 0.00 shares 10-Q · filed 2018-10-30 | 0.00 shares 10-Q · filed 2018-10-30 | ||
| 2017-06-30 | 0.00 shares 10-Q · filed 2018-08-02 | 0.00 shares 10-Q · filed 2018-08-02 | ||
| 2017-03-31 | 0.00 shares 10-Q · filed 2018-05-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |